NEW YORK (GenomeWeb) – Personal Genome Diagnostics said today that it will now provide its PlasmaSelect 64 liquid biopsy test to advanced cancer patients receiving treatment at US Department of Veterans Affairs facilities.

The agreement makes PGDx the first to provide plasma-based genomic profiling to VA cancer patients, expanding on an existing contract under which patients also have access to the company's tissue-based CancerSelect 125 assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.